ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,998.74
-0.38%
US Tech 100
20,239.20
-0.65%
Dow Jones
44,722.06
-0.31%
Brent Oil
72.145
-0.35%
Bitcoin
95,675.25
-0.31%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mersana Therapeutics Inc (MRSN)

  7. Mersana Therapeutics Inc (MRSN) News

MRSN

Mersana Therapeutics (MRSN)

Mersana Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRSN
DateTimeSourceHeadlineSymbolCompany
11/15/20244:45PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
11/14/20245:45PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
11/13/202411:00AMAllPennyStocks.comThis Particular Biotech Stock Is Soaring On Two Key AnnouncementsNASDAQ:MRSNMersana Therapeutics Inc
11/13/20248:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRSNMersana Therapeutics Inc
11/13/20247:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
11/13/20247:00AMGlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
11/06/20248:00AMGlobeNewswire Inc.Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024NASDAQ:MRSNMersana Therapeutics Inc
10/29/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/29/20244:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/15/20246:55AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/07/20245:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
10/03/20248:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
09/13/20245:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
09/13/20245:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
08/13/20248:59AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRSNMersana Therapeutics Inc
08/13/20247:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
08/13/20247:00AMGlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
08/06/20248:00AMGlobeNewswire Inc.Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024NASDAQ:MRSNMersana Therapeutics Inc
06/12/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
06/12/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
06/12/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
06/11/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MRSN

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
USOTC
SANP
Santo Mining (CE)
USOTC
TSOI
Therapeutic Solutions (PK)
NASDAQ
NB
NioCorp Developments
USOTC
ERHE
ERHC Energy (CE)
USOTC
MONI
Moon Equity (PK)
NASDAQ
AMRN
Amarin
NYSE
IONQ
IonQ
USOTC
GDVM
Global Developments (PK)
NASDAQ
ENTA
Enanta Pharmaceuticals
USOTC
AZRH
Azure (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
AABB
Asia Broadband (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IFUS
Impact Fusion (PK)
NYSE
AMC
AMC Entertainment
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21